UPDATE 1-Roche moves to broaden Kadcyla use in biosimilar defense
February 05, 2019 at 02:03 AM EST
* Breast cancer drug bested Herceptin in trial (Adds background, comment from Roche)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|